MedPath

A Clinical Trial to see the effect of some Ayurvedic Formulation in the treatment of Vataja Abhishyanda with reference to Allergic Conjunctivitis

Phase 1
Not yet recruiting
Conditions
Vataja Abhishyanda, Allergic Conjunctivitis
Registration Number
CTRI/2018/06/014474
Lead Sponsor
Sane Guruji Arogya Kendra
Brief Summary

This study is open labeled clinical trial to see the effect of Bilva Panchamooladi Kwath Siddha Ghrita Aschyotana instilled twice daily for 10 days in eye/eyes of patients affected with Vataja Abhishyanda. The primary outcome will be effect of Aschyotana in Vataja Abhishyanda.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
70
Inclusion Criteria

Patients suffering from symptoms of Vataja Abhishyanda-Toda,Sangharsha,Shishirashruta,Alpa shopha.

Exclusion Criteria

Pittaja,Kaphaja,Raktaja Abhishyanda other complications like corneal opacity,corneal ulcer Systemic diseases like Broncheal Asthama,Allergic Bronchitis,Dermatitis,Allergic Rhinitis,DM,HTN etc will be excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Effect of Bilva Panchmooladi kwath siddha ghrita in vataja abhishyanda.The drug will be given for 10 days. The patients will be assessed before and after treatment. Total duration of study will be 18 months.
Secondary Outcome Measures
NameTimeMethod
To get relief from symptoms of Vataja Abhishyanda18 months

Trial Locations

Locations (1)

Sane Guruji Arogya Kendra, Hadapsar.

🇮🇳

Pune, MAHARASHTRA, India

Sane Guruji Arogya Kendra, Hadapsar.
🇮🇳Pune, MAHARASHTRA, India
Vd Supriya Suryakant Muddalwar
Principal investigator
8668844115
smuddalwar@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.